Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins
| Autor: | F, Degraeve, M, Bolla, S, Blaie, C, Créminon, I, Quéré, P, Boquet, S, Lévy-Toledano, J, Bertoglio, A, Habib |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
rho GTP-Binding Proteins
DNA Complementary Time Factors Pyridines Bacterial Toxins Blotting Western Protein Prenylation Mevalonic Acid Apoptosis Inhibitory Concentration 50 Bacterial Proteins Leucine Humans Lovastatin Enzyme Inhibitors Aorta Cells Cultured Nucleic Acid Synthesis Inhibitors Dose-Response Relationship Drug Membrane Proteins Muscle Smooth Blotting Northern Amides Epoprostenol Isoenzymes Cyclooxygenase 2 Prostaglandin-Endoperoxide Synthases Dactinomycin Hydroxymethylglutaryl CoA Reductases Hydroxymethylglutaryl-CoA Reductase Inhibitors Interleukin-1 |
| Zdroj: | The Journal of biological chemistry. 276(50) |
| ISSN: | 0021-9258 |
| Popis: | Cyclooxygenase (COX)-2 and COX-1 play an important role in prostacyclin production in vessels and participate in maintaining vascular homeostasis. Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, which is crucial in cholesterol biosynthesis. Recently, cholesterol-independent effects of statins have been described. In this study, we evaluated the effect of two inhibitors of HMG CoA reductase, mevastatin and lovastatin, on the production of prostacyclin and the expression of COX in human aortic smooth muscle cells. Treatment of cells with 25 microm mevastatin or lovastatin resulted in the induction of COX-2 and increase in prostacyclin production. Mevalonate, the direct metabolite of HMG CoA reductase, and geranylgeranyl-pyrophosphate reversed this effect. GGTI-286, a selective inhibitor of geranylgeranyltransferases, increased COX-2 expression and prostacyclin formation, thus indicating the involvement of geranylgeranylated proteins in the down-regulation of COX-2. Furthermore, Clostridium difficile toxin B, an inhibitor of the Rho GTP-binding protein family, the Rho selective inhibitor C3 transferase, and Y-27632, a selective inhibitor of the Rho-associated kinases, targets of Rho A, increased COX-2 expression whereas the activator of the Rho GTPase, the cytotoxic necrotizing factor 1, blocked interlukin-1alpha-dependent COX-2 induction. These results demonstrate that statins up-regulate COX-2 expression and subsequent prostacyclin formation in human aortic smooth muscle cells in part through inhibition of Rho. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|